[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627686":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":23,"locations":29,"responsibleParty":42,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":66,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Kırıkkale University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Non CTO",null,"CTO (chronic total occlusion)",[13],"Diagnostic Test: triglyceride-glucose (TyG) index was calculated from routinely obtained blood samples using the formula: Triglyceride (mg\u002FdL) × Glucose (mg\u002FdL) \u002F 2.",{"label":15,"type":10,"description":11,"interventionNames":16},"CTO",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DIAGNOSTIC_TEST","triglyceride-glucose (TyG) index was calculated from routinely obtained blood samples using the formula: Triglyceride (mg\u002FdL) × Glucose (mg\u002FdL) \u002F 2.","As no previous studies have demonstrated the predictive value of the TyG index for chronic total occlusion (CTO), the present investigation provides a novel contribution to the literature. We hypothesize that the triglyceride-glucose (TyG) index will be significantly higher in patients with chronic total occlusion (CTO) compared to those without CTO.",[15,9],[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"RUKİYE GÖNEN ÖZDEMİR","CONTACT","+905054503953","rukiye_gonen@hotmail.com",[30],{"facility":31,"status":10,"city":32,"state":10,"zip":10,"country":33,"countryCode":10,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Kırıkkale university","Kirikkale","Turkey (Türkiye)",{"type":35,"coordinates":36},"Point",[37,38],33.50639,39.84528,{"lat":38,"lon":37},[41],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Rukiye Gonen Ozdemir","M.D","100627686","chronic-total-occlusion-and-triglyceride-glucose-index-100627686",false,"NCT07451860","Chronic Total Occlusion and Triglyceride-Glucose Index","The Role of the Triglyceride-Glucose Index in Determining the Risk of Chronic Total Occlusion in Coronary Artery Disease","Inclusion Criteria:\n\n* Adults ≥18 years of age, patients undergoing coronary angiography, non-obese individuals\n\nExclusion Criteria:\n\n* Patients \\\u003C18 years of age, history of atrial fibrillation, pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease, obesity (BMI \\>30 kg\u002Fm²), inaccessible patient records",true,"ALL","18 Years",{"count":57,"type":58},200,"ESTIMATED","1 Day","OBSERVATIONAL","We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.",[63,64,65],"CAD - Coronary Artery Disease","Chronic Total Occlusion (CTO)","Triglycerid Glucose Index","NOT_YET_RECRUITING","2026-02-28",{"date":69,"type":70},"2026-03-05","ACTUAL",{"date":72,"type":58},"2026-03-15",{"date":74,"type":58},"2026-09-15",{"name":5,"class":6},1]